These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 13855379)
1. [Pharmacological properties of the metabolites of 1,2-diphenyl-3,5-dioxo-4-n-butylpyrazolidine]. WILHELMI G Arzneimittelforschung; 1960 Feb; 10():129-33. PubMed ID: 13855379 [No Abstract] [Full Text] [Related]
2. [On the effect of 3, 5-dioxo-1, 2-diphenyl-4-butylpyrazolidine on the synthesis of fatty acids]. von BRAND Arzneimittelforschung; 1959 Dec; 9():767-9. PubMed ID: 13803850 [No Abstract] [Full Text] [Related]
3. [Experimental studies on the influence of 3, 5-dioxo-1-phenyl-2-p-hydroxphenyl)-4-n-butylpyrazolidine on the uptake of S35 -sulfate by corneal tissue]. MUENICH W Arzneimittelforschung; 1961 Aug; 11():773-5. PubMed ID: 14476969 [No Abstract] [Full Text] [Related]
4. [Increased effectiveness of cytosatic therapy by promoting absorption of Ehrlich ascites with 1-phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-n-butylpyrazolidine monohydrate]. GRAEBNER H Arzneimittelforschung; 1963 May; 13():371-5. PubMed ID: 13949724 [No Abstract] [Full Text] [Related]
5. [The effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl pyrazolidine and 3,5-dioxo-1-phenyl-2-p-hydroxyphenyl-4-butyl pyrazolidine on the incorporation of C14-leucine into the blood plasma proteins of the isolated rat liver]. JUNGBLUT PW Arzneimittelforschung; 1959 Sep; 9():549-51. PubMed ID: 14408193 [No Abstract] [Full Text] [Related]
6. [About the glucoside of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidine (phenylbutazone)]. MOREL CJ Experientia; 1958 Aug; 14(8):294-5. PubMed ID: 13574145 [No Abstract] [Full Text] [Related]
7. [Effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine on phosphatases. 2]. OHLMEYER P; KROMER H Arzneimittelforschung; 1958 Apr; 8(4):247-8. PubMed ID: 13535368 [No Abstract] [Full Text] [Related]
8. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine on phosphatases]. HAHN E; PLATE B Arzneimittelforschung; 1956 Dec; 6(12):728-9. PubMed ID: 13395936 [No Abstract] [Full Text] [Related]
9. Effect of phenylbutazone (3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin) on renal function. CAMPBELL EF Proc Soc Exp Biol Med; 1953 Nov; 84(2):481-3. PubMed ID: 13121080 [No Abstract] [Full Text] [Related]
10. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine (butazolidine) on cortisone metabolism in rat liver]. DIRSCHERL W; KORUS W; SCHRIEFERS H Arzneimittelforschung; 1956 Oct; 6(10):596-8. PubMed ID: 13373678 [No Abstract] [Full Text] [Related]
11. [The effect of 3,5-dioxo-1,2-diphenyl-4-nbutylpyrazolidine on phosphatases. Part 3]. OHLMEYER P Arzneimittelforschung; 1959 Oct; 9():653-4. PubMed ID: 14428452 [No Abstract] [Full Text] [Related]
12. [Toxicity and antiphlogistic effects of 4-(3-chloro-3-buteny1)-1,2-diphenyl-3,5-pyrazolidinedione]. LENFELD J; KROUTIL M; BOCEK M; CTVRTNIK J; MAYER J Arzneimittelforschung; 1961 Apr; 11():427-9. PubMed ID: 13760809 [No Abstract] [Full Text] [Related]
13. Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects. YU TF; SIROTA JH; GUTMAN AB J Clin Invest; 1953 Nov; 32(11):1121-32. PubMed ID: 13108975 [No Abstract] [Full Text] [Related]
14. Metabolites of feprazone in man. Yamaguchi H; Kubo J; Sekine K; Naruchi T; Hashimoto Y; Kato R Drug Metab Dispos; 1979; 7(5):340-4. PubMed ID: 40778 [TBL] [Abstract][Full Text] [Related]
15. [1-Phenyl-2-p-hydroxyphenyl-3,5-dioxo-4-D-butylpyrazolidine. Therapeutic use and hepatic functional effect]. RESIDORI G Gazz Int Med Chir; 1962 Sep; 66():1968-75. PubMed ID: 13981733 [No Abstract] [Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Phenylbutazone (CAS No. 50-33-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1990 Mar; 367():1-205. PubMed ID: 12692637 [TBL] [Abstract][Full Text] [Related]
17. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone. Kellermann G; Luyten-Kellermann M; Horning M; Stafford M Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834 [TBL] [Abstract][Full Text] [Related]